Indivior Pharmaceuticals (INDV) Prepaid Assets (2023 - 2026)
Indivior Pharmaceuticals (INDV) recorded quarterly Prepaid Assets of $40.0 million in Q1 2026, up 17.65% quarter-over-quarter from $34.0 million in Q4 2025, and down 28.57% on a YoY basis from $56.0 million in Q1 2025.
Indivior Pharmaceuticals (INDV) Prepaid Assets (2023 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Prepaid Assets history runs 4 years deep, the most recent figure standing at $40.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 28.57% year-over-year to $40.0 million; the TTM figure through Mar 2026 stood at $40.0 million (down 28.57% YoY), while the FY2025 annual figure was $34.0 million, up 9.68% from the prior year.
- Prepaid Assets was $40.0 million for Q1 2026 at Indivior Pharmaceuticals, up from $34.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $56.0 million in Q1 2025 to a low of $19.0 million in Q3 2025.
- Historically, Prepaid Assets has averaged $37.1 million across 4 years, with a median of $34.0 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 40.38% in 2024, then climbed 9.68% in 2025.
- A 4-year view of Prepaid Assets shows it stood at $52.0 million in 2023, then tumbled by 40.38% to $31.0 million in 2024, then rose by 9.68% to $34.0 million in 2025, then rose by 17.65% to $40.0 million in 2026.
- The last three Prepaid Assets figures came in at $40.0 million (Q1 2026), $34.0 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Indivior Pharmaceuticals | - | - | 277.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 34.00 Mn |
| Sep 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 28.00 Mn |
| Mar 31, 2025 | 56.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2023 | 52.00 Mn |